Related by context. All words. (Click for frequent words.) 66 Orphan Products 63 Fast Track Status 62 Qualified Therapeutic Discovery 62 Soliris TM eculizumab 61 FDA Orphan Drug 61 StromaCel Inc. 61 liver resection surgeries 61 Product Designation 61 ELADUR ™ 61 Integrated Preclinical 61 ADVEXIN p# therapy 60 Orphan Drugs 60 Receives Orphan Drug 60 Awarded Qualifying Therapeutic 60 Granted Orphan Drug 60 Diabetes Physician Recognition 60 NIH NIAID 60 Receives Fast Track 60 Receives CE Marking 60 Orphan Drug designation 60 FOLOTYN ® 59 Nanobody R 59 Orphan Drug Designation 59 GTC recombinant form 59 Cellegesic 59 Prism Pharmaceuticals 59 Panzem R 59 Orphan Drug status 59 RECOTHROM ® 59 Orphan Status 59 Ercole Biotech 59 Therapeutic Discovery 59 candidate epratuzumab 59 Somatuline R Autogel R 59 Initiates Enrollment 59 Syntonix 59 Liprotamase 59 Surfaxin LS 59 Protexia ® 59 Orphan Drug designations 59 Expanded Indication 59 HELSINN 59 EGRIFTA TM 59 XIAFLEX ™ 59 Accelerated Approval 59 Fast Track Designation 59 COLAZAL R 59 BioNumerik 59 ATryn ® 59 Argatroban 58 RECOTHROM R 58 Fast Track designations 58 Nycomed GmbH 58 personalized cellular immunotherapy 58 Gamunex C 58 intravesical infusion therapy 58 TRANSDUR ® 58 HuCAL antibodies 58 aerosolized AAT 58 BioDelivery Sciences Announces 58 QTDP 58 Orphan Designation 58 subsidiaries visit http:/www.apricusbio.com 58 Ceflatonin ® 58 SBIR Grant 58 acetonide FA 58 ZFP Therapeutics 58 VIVITROL ® 58 Tibotec BVBA 58 successfully commercialize Iluvien 58 Research Program LFRP 58 Angiox ® 58 Fortical R 58 Therapeutic Discovery Project 58 IL# PE#QQR 58 nasal calcitonin product 58 Drug Eluting Stent System 58 ZEFTERA TM Zevtera TM 58 Voraxaze 58 Personalized Immunotherapy 57 Receives Approvable Letter 57 DPX Survivac 57 KNS # 57 Somatuline Depot 57 OLEPTRO 57 rxRNA 57 PF # [002] 57 Alseres 57 Juvantia 57 Government Qualifying Therapeutic 57 Meritage Pharma 57 SYCREST 57 IND Filing 57 orphan designation 57 CREON 57 GVAX cancer 57 Orphan Drug 57 Loramyc TM 57 Successfully Completes Phase 57 Aviptadil 57 Romiplostim 57 Immunotherapeutic 57 Prodarsan R 57 Sinobiopharma 57 HuMax TAC 57 tizanidine hydrochloride short 57 Clinical Translational 57 Cellular Tissue 57 RhuDex 57 cinacalcet HCl 57 Orphan Drug Act 57 Initiates Phase III 57 Prochymal TM 57 Wellstat 57 Synerx 57 Kuvan R 57 R#/MEM 57 PDUFA Date 57 RxKinetix 57 Lung Rx 57 Orapred ODT 57 Galenea 57 Files IND 57 markets HP Acthar 57 ZLB Behring 57 HDL Selective Delipidation 57 Phenomix Corporation 57 Kosan dependence 57 Agios Pharmaceuticals 57 Oral Calcitonin 57 CRMD# 57 orphan medicinal product 57 NIH SBIR 57 TRO# 57 PSIC Grant 57 Synerx Pharma 57 ImQuest 57 Peer Reviewed Medical 56 Sigma Tau Pharmaceuticals 56 EyeGate Pharma 56 Vaccine Adjuvants 56 Vitrasert R 56 Glassia 56 OMAPRO ™ 56 Fillanthropy Program 56 eprodisate KIACTA TM 56 InterfeRx 56 RNAi Therapeutics 56 Juvaris BioTherapeutics 56 Psoriasis Drug 56 INTEGRILIN R eptifibatide Injection 56 5 lipoxygenase activating 56 FDA Accepts 56 Translational Science Award 56 Neovasc Reducer 56 glucokinase activator 56 Abstract Accepted 56 Teikoku Pharma USA 56 Qualifying Therapeutic Discovery 56 Nasdaq Delisting Notification 56 TKM Ebola 56 Uracyst R Test 56 QTDP grant 56 Keppra ® levetiracetam 56 ALN PCS 56 Nanotechnology Characterization Laboratory 56 Cethrin R 56 Bafetinib 56 Acetavance TM 56 Protexia R 56 Ganite ® 56 Genentech BioOncology 56 Albugon 56 Development Authority BARDA 56 OTCBB URGP specialty 56 immunotherapies 2A/Furin 56 enoxaparin sodium injection 56 AB OMXS BINV 56 HYVISC ® treatment 56 Pegloticase 56 Alnylam Biotherapeutics 56 orphan medicinal 56 Civacir 56 Milestone Payment From 56 RNAi Therapeutic 56 Orphan medicinal 56 ATryn R 56 Rhucin ® recombinant 56 Bertek Pharmaceuticals 56 Milestone Payment 56 Vaccinex 56 FACTIVE R gemifloxacin 56 Tectin TM 56 GATTEX TM 56 Therapy Evaluation 56 Quark Biotech 56 methylnaltrexone bromide 56 GTC recombinant human 56 VISICOL R 56 NSF SBIR 56 Evaluation Program CTEP 56 Aloxi R 56 Cethrin 56 Completes Patient Enrollment 56 Sylvie Gregoire President 56 Receives Orphan Drug Designation 56 Initiate Clinical Trial 56 Zenvia ™ 56 Nabi HB Intravenous 56 Pediatric Exclusivity 56 Protalex Inc. 56 recombinant biopharmaceutical 55 anthrax monoclonal antibody 55 Cerimon Pharmaceuticals Inc. 55 Immunomedics Announces 55 NASDAQ Delisting Notice 55 TaiGen 55 Captisol ® 55 Fabry Disease 55 Orphan designation 55 Perforomist ™ Inhalation Solution 55 Investigator Initiated 55 Bellicum 55 Creabilis Therapeutics 55 CHMP recommendation 55 Training IACET 55 Enzyme Replacement Therapy 55 Receive Milestone Payment 55 Initiates Clinical Trial 55 pregabalin Lyrica 55 Telik Announces 55 See CLINICAL PHARMACOLOGY 55 ZARS Pharma 55 Reports Preclinical Data 55 BioDelivery Sciences 55 product platforms AZX# 55 PD2i Analyzer 55 ENLIGHT 55 systemic immunosuppressive drugs 55 Meets Primary Endpoint 55 ddRNAi 55 JAK2 Inhibitor 55 SUMAVEL DosePro 55 Prometheus Laboratories 55 CryoSeal FS System 55 trastuzumab DM1 T DM1 55 Enhanze 55 Thrombin topical Recombinant 55 IDEV Technologies 55 Spirus Medical 55 Initiates Clinical 55 Expedited Review 55 M Enoxaparin 55 Receives Milestone Payment 55 Quark Pharmaceuticals 55 GeoVax AIDS vaccine 55 Aeolus Pharmaceuticals Announces 55 PrevOnco 55 MultiCell Technologies 55 Orphan Drug Status 55 MOVIPREP R 55 Sirion Therapeutics 55 Addrenex Pharmaceuticals 55 Oracea TM 55 Exploit collaboration 55 Ichor Medical Systems 55 Fovea Pharmaceuticals 55 Marillion Pharmaceuticals 55 mertansine 55 INSPIRE Trial Phase III 55 OvaRex R 55 Selective Electrochemical Tumor Ablation 55 UCB Pharma SA 55 Novacort 55 dihydrochloride Tablets 55 GRNVAC1 55 NOXXON 55 R sorafenib tablets 55 InterfeRx TM 55 Lipocine 55 Cardiovascular Stents under 55 Intarcia 55 BY WILLA J. 55 Celladon Corporation 55 UCB Pharma 55 TOPICA 55 Project QTDP 55 Generic Versions 55 AnGes MG Inc. 55 Amarillo Biosciences 55 delivers fluocinolone acetonide FA 55 PORxin TM platforms 55 Plexxikon proprietary 55 Submits Response 55 Skin Cholesterol Test 55 ViaCyte 55 QTDP program 55 Nasdaq Delisting Notice 55 CyDex Pharmaceuticals 55 Silodosin 55 microRNA Therapeutics 55 Submits Biologics License Application 55 Genetronics 55 Kaketsuken 55 SNT MC# 55 Pandemic Influenza Vaccines 55 RHEI Pharmaceuticals 55 Chemokine Therapeutics 55 Military Malaria Vaccine 55 Issued Patent 55 Novel Drug Eluting 55 End Duchenne 55 ORENCIA R 55 Anthony Giovinazzo 55 Aryplase 55 ProEthic Pharmaceuticals 55 LibiGel ® 55 UltiMAb 55 Investigational Device Exemption 55 Zenpep 55 LGLS 54 NSF Integrative Graduate 54 Zygogen 54 Application MAA 54 Preotact 54 Teva Provides Update 54 BioElectronics Corporation Announces 54 RANK Ligand inhibitor 54 ARRY # 54 Sopherion 54 Xyrem ® 54 Friedreich Ataxia FRDA 54 Microbix Biosystems 54 ImmunoCellular Therapeutics 54 tiapamil 54 Discovery Project QTDP 54 SUPPRELIN R LA 54 Spiegelmer ® 54 Obtains CE Mark 54 acyclovir Lauriad R 54 Etanercept 54 Grants Orphan Drug 54 HepaGam B 54 SUTENT ® 54 Novel Vaccine 54 Patent Broadly Covering 54 ferumoxytol Injection 54 HQK 54 SIX RO ROG 54 Circ Pharma 54 Cell Transplant 54 BYETTA ® 54 PriCara ® 54 Frova ® 54 Recombinant Protein 54 ICAEL 54 Dr. Gulfo 54 Tesmilifene 54 FoldRx 54 AnGes 54 Evoltra ® 54 pralatrexate injection folate analogue 54 MyVax ® 54 Organon Pharmaceuticals 54 Irvine Sensors Receives 54 NHGRI Division 54 ImmunoVaccine Technologies 54 BioAxone 54 SCIB1 54 Hedgehog antagonist 54 BioSyent Pharma 54 Campath ® 54 therapeutic monoclonal antibodies 54 SansRosa 54 Ketotransdel 54 ORADUR ADHD 54 Nuvelo Announces 54 mesylate tablets approved 54 NDA Submission 54 kidney urologic 54 Ebola Vaccine 54 Bioheart Inc. 54 Defense Congressionally Directed 54 TYZEKA 54 Cenomed 54 molecular imaging radiopharmaceutical 54 Enobia 54 Verus Pharmaceuticals 54 Ingenuity Pathways Analysis 54 Dexilant 54 Translational Biology 54 OLEPTRO TM 54 DiscoveRx 54 EndoBiologics 54 Lupin Pharmaceuticals Inc 54 NPC 1C 54 nicotinic alpha 7 54 Nuclear Receptors 54 Cara Therapeutics 54 URG# 54 Belimumab 54 t2cure GmbH 54 Frozen Shoulder syndrome 54 Valortim TM 54 ISTO Technologies 54 Supernus 54 Acute Heart Failure 54 Regado Biosciences 54 Increlex TM 54 topically applied SEPA 54 Methylphenidate Transdermal System 54 sorafenib tablets 54 Tibotec Therapeutics division 54 Islet Transplantation 54 NIAID NIH 54 Nutritional Metabolism 54 Intramural Research 54 EOS NASDAQ MELA 54 Marketing Authorization 54 BLP# Liposome Vaccine 54 5 lipoxygenase inhibitor 54 Vion Pharmaceuticals 54 BrachySil TM 54 Rotarix ® 54 ABILIFY ® 54 BRILINTA 54 Exclusive License 54 Frova R 54 Submits NDA 54 EnzymeRx 54 Marketing Authorisation 54 DexaSite 54 Patient Enrollment 54 BioGeneriX 54 GLASSIA 54 NeuroSolutions 54 BiovaxID TM 54 HCV Protease Inhibitor 54 Scaffold Based 54 XIAPEX 54 ENZON 54 k Premarket Notification 54 Supplemental Biologics License Application 54 PGL# 54 SIPconnect Compliant Certification 54 Akorn Strides 54 Degarelix 54 Emisphere Technologies 54 Biologics Manufacturing 54 Sanvar R 54 Schizophrenia Drug 54 Myrexis Inc. 54 omacetaxine mepesuccinate 54 Teikoku Seiyaku Co. 54 Rotarix R 54 Dr. Damaj 54 CIMZIA r 54 Novel Approaches 54 Sumavel DosePro 54 IRS Qualifying Therapeutic 54 Application BLA 54 PHX# 54 GAMMAGARD 54 Bioral 54 Scynexis 54 ImmuneWorks 53 budesonide MMX Phase III 53 Pivotal Phase III 53 Pafuramidine 53 novel peptides 53 investigational pharmacologically unique 53 Generic Version Of 53 Alnara Pharmaceuticals 53 Loramyc ™ 53 Translational Science Awards 53 Schizophrenia Treatment 53 Kyowa Kirin 53 oral PTH 53 SoluBest 53 Tostrex 53 PREOS R 53 Veridex LLC 53 Phase III Clinical Trial 53 Cx# [002] 53 Xyfid TM 53 Factor VIIa 53 Foradil Aerolizer 53 Trubion Pharma 53 NIH NHLBI 53 HYVISC R 53 CONBRIZA 53 Somatuline Autogel 53 Nitec 53 Ixempra 53 Esbriet pirfenidone 53 Niris Imaging System 53 Positive Opinion 53 Inc. dba Vitro 53 class mGluR5 inhibitor 53 Simulect 53 refractory chronic lymphocytic 53 Antibody Drug Conjugate 53 TriLink BioTechnologies 53 BLSI 53 PentaStaph 53 GED aPC 53 purinergic receptors P#X# 53 Clinical Translational Science 53 Kosan epothilone program 53 Gord Froehlich President 53 Helsinn 53 TESARO 53 Addrenex 53 Chugai Pharma USA 53 BEMA Granisetron 53 Zolpimist ™ 53 systemic RNAi 53 Tomophase 53 Biotica 53 NOBEX 53 DepoDur R 53 Combidex 53 THALOMID 53 Aegerion Pharmaceuticals 53 Expression Genetics 53 Potelligent TM 53 Ascend Therapeutics 53 VIAP 53 MyVax R 53 Dietary Supplements ODS 53 Glaucoma Treatment 53 AMEX RGN 53 Ostarine ™ 53 DiaKine 53 DOR BioPharma Announces 53 Modrenal R 53 Retacrit 53 Mersana Therapeutics Inc. 53 Accentia Biopharmaceuticals 53 DIFICID ™ 53 Biologic License Application BLA 53 Gentamicin Surgical Implant 53 Research CDER 53 Numoda 53 Femring ® 53 PhotoCure 53 Mesoblast Limited ASX MSB 53 Fibrocell Science 53 PDE4 inhibitor 53 Tolerx 53 Viamet 53 Dr. Arndt Schottelius 53 Receives ISO #:# [002] 53 Referenced EEG 53 Prestara 53 Myocet 53 MEK Inhibitor 53 ALVESCO R 53 Dacogen injection 53 vitreoretinal disorders 53 Loramyc R 53 Small Molecule 53 Othera Pharmaceuticals Inc. 53 RNA antagonists 53 BioSpecifics Technologies Corp. 53 Transdermal Drug 53 Pirfenidone 53 Source MDx 53 EpiTherapeutics 53 GeneraMedix Inc. 53 Caring Ambassadors 53 Pfizer Ophthalmics 53 NIBIB 53 POSIDUR ™ 53 CINQUIL 53 Myoblast 53 AVI BioPharma Announces 53 markets Gelclair R 53 Commercialize Novel 53 CERVARIX R 53 targeted radiotherapeutic 53 FRSQ 53 Lupin Pharmaceuticals Inc. 53 Curaxin 53 Prostate Cancer Vaccine 53 IV APAP 53 forodesine 53 Soliris eculizumab 53 Zingo TM 53 Option IVC Filter 53 VitiGam 53 Daniel Tasse 53 Phase 2b Clinical Trial 53 C3 Jian 53 Congressionally Directed Medical 53 BioRexis 53 Therapeutic Antibodies 53 Oasmia 53 Proquin XR 53 NASDAQ OSIR 53 Sankyo Pharma Inc. 53 please visit www.metabolon.com 53 Formatech 53 tramiprosate ALZHEMED TM 53 CLIA waiver 53 Alnylam Pharma 53 Iluvien ® 53 Bexion 53 Dannon Next Generation 53 NCI Cancer 53 Trobalt 53 ESA APPRISE Oncology 53 DOV Pharmaceutical 53 Adenosine Therapeutics 53 novel synthetic PEGylated 53 PNP inhibitor 53 BioWa 53 Nasdaq Deficiency Notice 53 cathepsin K inhibitor 53 GRAS Status 53 Onco TCS 53 Elan NanoCrystal 53 Melanoma Vaccine 53 GVAX Pancreas Vaccine 53 MacroMed 53 AVANIR Pharmaceuticals Announces 53 exclusive sublicense 53 ASX PGL 53 Octreolin 53 ParAllele 53 MAGE A3 ASCI 53 Oncobionic 53 ZALBIN 53 Plicera 53 Radiopharmaceutical 53 Pyridorin 53 TKM ApoB 53 ONSOLIS 53 Patient Enrolment 53 Hedgehog Pathway Inhibitor 53 Fresenius Biotech 53 Ridaforolimus 53 Luveniq 53 rThrombin 53 zileuton CR 53 Australian Therapeutic Goods 53 Circulatory Support 53 Janssen Pharmaceutica NV 53 TransVax ™ 53 Pharnext 53 OREF 53 AzaSite TM 53 Cardiac Stem Cell 53 Bioral Amphotericin B 53 miRNA therapeutics 53 AAHRPP accreditation 53 adrenergic regulation 53 Phenomix 53 Fibrillex TM 53 Enters Into Collaboration 53 SuperAntibody 52 severe hypercholesterolemia 52 Pain Neutralizer holds 52 Orphan Medicinal Product 52 PDS Biotechnology 52 Aurexis 52 Inovio Pharmaceuticals 52 Dr. Jacob Bolotin 52 ACEON R perindopril erbumine 52 SNS# T 52 ProLindac TM 52 NicVAX TM 52 Corixa Corporation 52 MPS VI 52 Thelin TM 52 Arno Therapeutics 52 SIMCOR ® 52 Cardioxyl Pharmaceuticals 52 ATPace TM 52 ONCASPAR 52 Zorbtive TM 52 Genasense ® oblimersen 52 Elagolix 52 Bucindolol 52 Ortho Dermatologics 52 Prolongs Survival 52 equine osteoarthritis 52 candidate Zenvia 52 Composite Coatings 52 Testosterone Gel 52 drug ISA# 52 Gemstone Acquisition 52 Ophthotech 52 Cascade LifeSciences 52 Etubics 52 Aegera 52 Dell ISV Partner 52 Kiadis Pharma 52 visit www.lupus.org 52 CMV vaccine 52 Outcome Sciences 52 CAMPATH 52 EyeGate 52 ProFibrix 52 BioMarin Genzyme LLC 52 investigational antiplatelet agent 52 Glybera R 52 InvaGen 52 IGIV therapy 52 Novel Therapies 52 EDEMA3 trial 52 vaginally administered lidocaine 52 Cytori NASDAQ CYTX 52 Brussels THR 52 MAA submission 52 Proellex TM 52 Presents Preclinical Data 52 EHT AGN 52 Mohawk Boosters 52 Amigal TM 52 Insegia 52 A. Martinos 52 Aflibercept 52 BXT # 52 Max Neeman 52 Paramount BioSciences 52 targeted anticancer biopharmaceuticals 52 small molecule thrombopoietin 52 iCardiac 52 RAPTIVA 52 Cytori Therapeutics NASDAQ CYTX 52 Cellective Therapeutics 52 Patient Oriented 52 Apricus Bio 52 novel histone deacetylase 52 Icatibant 52 SafeStitch Medical 52 Adamis Pharmaceuticals 52 Tramadol ER 52 Euronext Amsterdam GLPGA 52 sitaxsentan sodium 52 THALOMID R 52 OMP designation 52 Product Commercialization 52 DF HCC 52 Biologics License Applications 52 pediatric exclusivity 52 Zavesca r 52 Canvaxin 52 Astex Therapeutics 52 MAXY G# 52 PDL BioPharma Announces 52 NASA Terrestrial Ecology 52 prokinetic agent 52 Onalta 52 StromaCel 52 levocetirizine 52 FluoroPharma 52 ALZA Corporation 52 Bioengineering NIBIB 52 Nexavar prescribing 52 Manja Bouman CEO 52 NitroMist TM 52 ERYtech Pharma 52 subcutaneous formulation 52 Cleveland BioLabs 52 alvimopan 52 pseudobulbar affect PBA 52 Tumor Microenvironment 52 Raptiva R 52 Immutep 52 Bazedoxifene 52 Singulex 52 BTG plc 52 ALN HTT 52 Enzo Therapeutics 52 candidate TNFerade biologic 52 ONTAK 52 DNA RNA Medicines 52 Zanaflex Capsules TM 52 Ascent Therapeutics 52 Nasdaq OMER biopharmaceutical 52 Nanotherapeutics 52 miRagen Therapeutics 52 Shanghai Wanxing 52 Pediatric Oncology Branch 52 BENECOL R Spreads 52 rPA Anthrax Vaccine 52 AMITIZA ® 52 BioSTAR R 52 RNA Therapeutics 52 Ryogen 52 BENLYSTA ® 52 Santhera 52 IRX 2 52 OrSense 52 FzioMed 52 BioGeneriX AG 52 IMiDs 52 miRagen 52 Ca DTPA 52 Cinryze ™ 52 Accelovance 52 Tetrabenazine 52 iBioLaunch platform 52 NABTT 52 Therapeutic Vaccine 52 oral prodrug 52 Zegerid OTC 52 Quark Biotech Inc. 52 Biopartners 52 Foundation ADDF 52 SFDA Approval 52 Additional Stock Repurchase 52 VNS Therapy TM 52 therapeutic monoclonal antibody 52 Merrimack Pharmaceuticals 52 Exalgo 52 ALN VSP Phase 52 Physician Scientist 52 BioMarck 52 ONCONASE R 52 Janssen Ortho Inc. 52 LUCASSIN 52 Génome Québec 52 IMA# 52 Clinical Trials Agreement 52 recombinant subunit vaccine 52 Genetic Therapies Directorate 52 EnVivo 52 Patent Covering 52 Nanophase Announces 52 BLA filing 52 StemEx R 52 AVAX 52 Ventrus 52 Cancer Immunotherapeutics 52 Ortho Clinical 52 Charlesson 52 Louis Drapeau 52 Aegerion 52 HepaSphere 52 Ibis Biosciences 52 VIRxSYS 52 dextromethorphan quinidine 52 Translational Breast Cancer 52 Japanese Encephalitis Vaccine 52 MoxDuo IV 52 Anti CD# Antibody 52 Companion Diagnostic 52 Investigational Treatment 52 Angioblast 52 Hematological Malignancies 52 Supernus Pharmaceuticals 52 Sidec 52 Heska Announces 52 FIRMAGON R 52 Galderma SA 52 Neuroptix 52 Neurological Diseases 52 novel VDA molecule 52 Epiphany Biosciences 52 AERx iDMS 52 Bicifadine 52 DermTech International 52 SparVax ™ 52 Therapeutic Antibody 52 YONDELIS 52 Semafore Pharmaceuticals 52 Omni Bio 52 Preotact R 52 WILEX 52 Molecular Profiling 52 Phase #b/#a clinical 52 Anti Infective 52 Vaccinogen 52 Molecular Biotechnology CMB 52 ZaBeCor 52 Immunex Corporation 52 NIH CounterACT 52 Ulrich Dauer CEO 52 NASDAQ DYAX 52 Uracyst ® 52 Innovative Partnerships Program 52 Allovectin 7 52 Sinuwave 52 FoldRx Pharmaceuticals Inc. 52 SCHWARZ PHARMA 52 Files Investigational 52 Prof. Pnina Fishman 52 Hsp# Inhibitor 52 Lung Flute ® 52 Isotechnika Pharma 52 Bionutrics 52 Legacy Biotechnologies 52 eligen 52 Fludara ® 52 Rheumatoid Arthritis Drug 52 Uracyst 52 Vaccine Adjuvant 52 FRDA 52 Dupuytren Contracture 52 VISTAKON 52 Arimoclomol 52 number NCT# ClinicalTrials.gov 52 Proteo 52 Chemokine 52 Fast Track designation 52 Diasome 52 Seikagaku 52 Biomarker Discovery Center 52 Teva Neuroscience 52 Homspera TM 52 torsemide ER 52 QOPI 52 Relistor 52 Senexis 52 pafuramidine 52 ThermoDox R 52 REGiMMUNE 52 Valtropin 52 novel oral anticoagulant 52 Zelrix 52 First Patient Dosed 52 VivaGel TM 52 lixivaptan 52 MedGenesis 52 interferon gamma 1b 51 BioDelivery 51 ACOMPLIA R 51 Nivestim 51 EnVivo Pharmaceuticals 51 Molecular Diagnostic Test 51 REVLIMID lenalidomide 51 Vernalis plc 51 supplemental biologics 51 reslizumab 51 iBio 51 Zirgan 51 MD Moross Institute 51 SYN X 51 TapImmune 51 #D#C# 51 TolerRx 51 Exelon rivastigmine 51 Phase 2a Trial 51 EKR Therapeutics 51 ALN TTR 51 Loramyc ® 51 QRxPharma 51 RhinoChill System 51 Circuit CAFC 51 Develop Novel 51 Avian Transgenic Technology 51 Pazopanib 51 FORMA Therapeutics 51 Starpharma dendrimer 51 Vilazodone 51 GARDASIL ® 51 Euroscreen 51 Ceflatonin R 51 Generex Biotechnology 51 Inhaled AAT 51 DiagnoCure Oncology Laboratories 51 Phase IIb clinical trials 51 ENTOCORT EC 51 Urokinase 51 Hybridon 51 iBIO Institute 51 Eligard R 51 Centralized Procedure 51 ISO #:# Certification [001] 51 Fenoglide 51 TORISEL TM 51 XTLbio 51 Septin 9 51 immunotherapeutic vaccine 51 gastrointestinal disorders characterized 51 AE# vaccine 51 topical NSAID 51 RNA Interference RNAi 51 UVIDEM 51 Sernova 51 IgG1 monoclonal antibody 51 Dynepo TM 51 Steven B. Ratoff 51 volociximab 51 InNexus Biotechnology 51 Gelclair R 51 commercialize deforolimus 51 P#X# antagonist 51 HHS Substance Abuse 51 Paladin Labs 51 BioTie 51 Allovectin 7 R 51 Onconase 51 non porcine pancreatic 51 RHEI 51 cellular immunotherapy